Coherus Biosciences Inc. (Nasdaq: CHRS) narrowed losses for the fourth quarter sending the stock price soaring $2.75 to close at $11.85.
Coherus Biosciences narrows losses
March 09, 2018 at 17:02 PM EST
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|